Cannula Market Share, Growth, Size and Demand Forecast 2024-2032 from Rohit Pujari's blog

Global Cannula Market Statistics: USD 267.6 Million Value by 2032

Summary:

• The global cannula market size reached USD 159.2 Million in 2023.
• The market is expected to reach USD 267.6 Million by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.
• North America leads the market, accounting for the largest cannula market share.
• Cardiac cannulas account for the majority of the market share in the product segment because of the rising incidence of cardiovascular disorders.     
• Straight cannulas hold the largest share in the cannula industry.
• 18G remains a dominant segment in the market due to its extensive and adaptable use in medical operations.
• Plastic (PVC) cannulas represent the leading material segment.
• On the basis of application, the market has been divided into cardiovascular surgery, oxygen therapy, general surgery, cosmetic/plastic surgery, orthopedic surgery, and others.
• Hospitals exhibit a clear dominance as they offer comprehensive care to patients.
• The rising number of surgical procedures is a primary driver of the cannula market.
• The increasing prevalence of chronic diseases and technological advancements are reshaping the cannula market.

Industry Trends and Drivers:

• Growing Surgical Procedures:

The rising number of surgical procedures across various medical specialties is propelling the market growth. There is an increase in the reliance on minimally invasive (MI) procedures, which require specialized cannulas for fluid and medication administration. In addition, the growth in elective surgeries, especially in areas, such as orthopedics, plastic surgery, and bariatric surgery, contributes to this demand. Hospitals and surgical centers are expanding their capabilities to manage more complex cases, leading to higher usage of cannulas for interventions like laparoscopic surgeries, endoscopic procedures, and catheterization. This trend not only highlights the importance of cannulas in enhancing surgical outcomes but also underscores the need for continuous innovation in design and functionality to cater to the diverse requirements of modern surgical practices. 

• Rising Prevalence of Chronic Diseases:

The increasing prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and cancer, among the masses around the world is bolstering the market growth. These conditions often require ongoing medical treatment and monitoring, which necessitates the use of cannulas for medication delivery, fluid management, and blood sampling. As populations age and lifestyle-related health issues become more prevalent, the demand for effective medical devices like cannulas rises. Furthermore, chronic disease management often involves multiple interventions, including regular surgeries and hospital visits, increasing the need for reliable cannula options. Healthcare systems are focusing on improving patient care quality for chronic disease management.      

• Technological Advancements:

Innovations in cannula design and materials are crucial drivers of the market. Recent advancements are leading to the development of safety-engineered cannulas designed to minimize the risk of needlestick injuries, enhancing patient and healthcare worker safety. Advancements, such as bioresorbable materials, advanced coatings, and improved ergonomics, contribute to better patient experiences and outcomes. Furthermore, smart cannulas integrated with sensors can monitor fluid delivery rates and patient vitals in real time, improving clinical decision-making. As a result, these technological improvements not only enhance the performance and safety of cannulas but also align with the growing demand for personalized and precise medical care.   

Request for a sample copy of this report: https://www.imarcgroup.com/cannula-market/requestsample

Cannula Market Report Segmentation:

Breakup By Product:

• Cardiac Cannulas
• Nasal Cannulas
• Vascular Cannulas
• Dermatology Cannulas
• Arthroscopy Cannulas
• Others

Cardiac cannulas account for the majority of shares because of the rising incidence of cardiovascular disorders.   

Breakup By Type:

• Neonatal Cannulas
• Straight Cannulas
• Winged Cannula
• Wing with Port Cannula
• Others

Straight cannulas dominate the market owing to their ability to provide accessibility, affordability, and simplicity.     

Breakup By Size:

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G

18G represents the majority of shares due to their extensive and adaptable use in medical operations.

Breakup By Material:

• Plastic (PVC) Cannulas
• Silicone Cannulas
• Metal Cannulas (Stainless Steel)

Plastic (PVC) cannulas hold the majority of shares on account of the increasing focus on maintaining sterile conditions and guaranteeing patient comfort.       

Breakup By Application:

• Cardiovascular Surgery
• Oxygen Therapy
• General Surgery
• Cosmetic/Plastic Surgery
• Orthopedic Surgery
• Others 

On the basis of application, the market has been divided into cardiovascular surgery, oxygen therapy, general surgery, cosmetic/plastic surgery, orthopedic surgery, and others.

Breakup by End-User:

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others

Hospitals exhibit a clear dominance as they offer comprehensive care to patients.   

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position owing to a large market for cannula driven by the presence of a sophisticated healthcare system.    

Top Cannula Market Leaders:

The cannula market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Boston Scientific Corporation
• CONMED Corporation
• Edwards Lifesciences
• Medtronic Plc
• Smith & Nephew PLC
• Smiths Medical Inc.
• LivaNova Plc
• Teleflex Incorporated
• Terumo Corporation.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1–631–791–1145